Groups Urge FDA To Halt Launch Of Zogenix, Inc. (ZGNX)'s Zohydro Pain Drug
2/28/2014 7:37:45 AM
(Reuters) - A coalition of addiction experts, physicians and others is urging U.S. health officials to reverse course and block the launch of a powerful painkiller called Zohydro, expected to hit the market next month.
The opioid drug, manufactured by Zogenix Inc, contains a potent amount of an active ingredient that could be lethal to new patients and children and is not safer than other current pain drugs, the groups told the Food and Drug Administration.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by